Literature DB >> 24101032

Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman.

Maram Abou Saleh1, Rose Ngozi Mafiana, Mohammed Al Za'abi, Ragini Vaishnav, Salam Al Kindi, Ibrahim Al-Zakwani.   

Abstract

BACKGROUND: Little is known about the incidence and burden of chemotherapy-induced neutropenia (CIN) in Oman or the Arabian Gulf.
OBJECTIVES: To determine the epidemiology of CIN at Sultan Qaboos University Hospital in Oman.
METHODS: A retrospective observational study of all eligible CIN episodes in adult (>18 years) patients with solid tumors and hematological malignancies at Sultan Qaboos University Hospital (SQUH) from January to December 2010. Analyses were performed using univariate statistics.
RESULTS: A total of 1,357 episodes in 159 patients with a mean age of 50 ± 15 years (19-91) were evaluated. Fifty-four percent (n = 86) of the patients were female. A total of 46 % (73/159) of the patients developed CIN accounting for 15 % (210/1,357) of all episodes. Twelve percent (25/210) of these CIN episodes were associated with fever in 26 % (19/73) patients. There was significant association between CIN and chemotherapy regimen (P < 0.001), younger age (P < 0.001), low hemoglobin (Hb) levels (P < 0.001) and advanced cancer stage (P = 0.006).
CONCLUSIONS: This study suggests a high incidence of CIN in SQUH patients which resulted in chemotherapy delays, longer hospital stays, and inpatient mortality. CIN was significantly correlated with chemotherapy regimen, younger age, low Hb levels and cancer stage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24101032     DOI: 10.1007/s11096-013-9859-8

Source DB:  PubMed          Journal:  Int J Clin Pharm


  7 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Leon E Cosler; Gary H Lyman
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

3.  Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors:  J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

Review 4.  Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies.

Authors:  E J Bow
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

5.  Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome.

Authors:  S al-Bahar; R Pandita; B N Dhabhar; E al-Bahar
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

6.  Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Authors:  D W Maher; G J Lieschke; M Green; J Bishop; R Stuart-Harris; M Wolf; W P Sheridan; R F Kefford; J Cebon; I Olver; J McKendrick; G Toner; K Bradstock; M Lieschke; S Cruickshank; D K Tomita; E W Hoffman; R M Fox; G Morstyn
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

7.  Impact of effective prevention and management of febrile neutropenia.

Authors:  D Krell; A L Jones
Journal:  Br J Cancer       Date:  2009-09       Impact factor: 7.640

  7 in total
  3 in total

1.  Nurses' knowledge of chemotherapy-induced neutropenia and its management: a cross-sectional survey.

Authors:  Mohammad Al Qadire; Cherry Ann C Ballad; Ma'en Aljezawi; Omar Al Omari; Fawwaz Alaloul; Ahmad Musa; Sulaiman Al Sabei; Atika Khalaf
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-12       Impact factor: 4.322

Review 2.  The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis.

Authors:  Ebtihag O Alenzi; George A Kelley
Journal:  J Diabetes Complications       Date:  2016-09-21       Impact factor: 2.852

3.  Profiling chemotherapy-associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens: epidemiological features, timing, predictors and clinical impacts.

Authors:  Ci Zhu; Yan Wang; Xicheng Wang; Chunmei Bai; Dan Su; Bing Cao; Jianming Xu
Journal:  J Cancer       Date:  2017-08-18       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.